Pano Anthos, founder and managing director of XRC Ventures, tells this week’s Video Forum about how innovations by emerging technology companies will help make community pharmacies the first line of defense in health care. He also discusses the pace of change in technology, health care and retailing, as well as the attitude of consumers toward new tools to maintain their well-being.
Video Forum: Pano Anthos, XRC Ventures
Pano Anthos, founder and managing director of XRC Ventures, tells this week’s Video Forum about how innovations by emerging technology companies will help make community pharmacies the first line of defense in health care.
Related
Kroger-Albertsons merger goes on trial in an Oregon federal court
The FTC faces off against lawyers from Albertsons and Kroger in a fight over competition in the grocery channel.
FDA approves Moderna’s updated COVID-19 vaccine
Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older.
Kroger sues FTC, claims merger challenge violates Constitution
The company argues that by proceeding in its administrative tribunal, in addition to the separate action in federal court, the FTC is violating Constitutional protections.
CRN to Federal Appeals Court: NY AG’s arguments don’t support denial of preliminary injunction in NY age restrictions case
CRN’s most recent brief argues that the NY AG does not meaningfully address CRN’s arguments about the Act’s constitutional infirmities.
Latest
USPS honors greeting cards with 'Happy Birthday' stamp
Creators and suppliers to celebrate the role of greeting cards in spreading joy.
Grocers play a vital health role
By Krystal Register, VP of health and well-being at FMI – The Food Industry Association
Preventive health trends fuel gut supplement market expansion
Consumers are increasingly turning to probiotics and digestive health solutions, reinforcing front-end growth opportunities for chain drug retailers.
Lupin launches Dapagliflozin tablets in the United States
The tablets are bioequivalent to Farxiga®.